Underpowered or negative? A crucial distinction. Reply to Dollerup OL, Treebak JT, Jessen N [letter]

Niels J. Connell, Riekelt H. Houtkooper, Patrick Schrauwen*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)1096-1096
Number of pages1
JournalDiabetologia
Volume62
Issue number6
DOIs
Publication statusPublished - Jun 2019

Keywords

  • Clinical trial
  • Human
  • NAD(+) metabolism

Cite this